Author

A. A. Kirichek

Observed names: A.A. Kirichek Kirichek, Andrei A. Kirichek, Andrey A. Kirichek, А.А. Киричек, Киричек Андрей Андреевич

Observed institutions: Russian Cancer Research Center NN Blokhin, Ministry of Health of the Russian Federation, Botkin Hospital, City Clinical Hospital, Central Clinical Hospital, Moscow City Oncology Hospital №62

ORCID: 0000-0002-3672-2369

Observed ORCID: 0000-0002-3672-2369

OpenAlex ID: A5017282067

Prostate cancer

2021 · Andrei D. Kaprin, Boris Ia. Alekseev, et al. · Journal of Modern Oncology · 17

PDF

Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-naïve prostate cancer

2019 · V.B. Matveev Matveev, A.A. Kirichek Kirichek, et al. · Urologiia · 11

The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer

2019 · V. B. Matveev, A. A. Kirichek, et al. · Cancer Urology · 10

PDF

Impact of PD-L1 status on the long-term outcomes of radical treatment of patients with prostate cancer

2019 · V.B. Matveev Matveev, A.A. Kirichek Kirichek, et al. · Urologiia · 8

Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer

2018 · V. B. Matveev, A. A. Kirichek, et al. · Cancer Urology · 6

PDF

Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?

2019 · M. I. Volkova, V. A. Ridin, et al. · Cancer Urology · 4

PDF

Risk-adapted approach to prostate cancer screening

2018 · A. A. Kirichek, L. N. Lyubchenko, et al. · Cancer Urology · 3

PDF

Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia

2022 · B. Ya. Alekseev, K. M. Nyushko, et al. · Cancer Urology · 2

PDF

On staging of urologic cancers in accordance with the updated 8th edition of the TNM Classification

2018 · A. A. Kirichek, B. Sh. Kamolov, et al. · Cancer Urology · 2

PDF

Efficacy of cabozantinib in the 1st line therapy of progressing multiple primary metachronous renal cell carcinomas: clinical observation

2025 · A. A. Kirichek, E. A. Sokolov, et al. · Cancer Urology · 1

PDF

An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia

2020 · B. Ya. Alekseev, K. M. Nyushko, et al. · Cancer Urology · 1

PDF

Review of the Oncological Urology Proceedings of the American Society of Clinical Oncology (asco) 2018 Annual Meeting

2018 · A. A. Kirichek, B. Sh. Kamolov, et al. · Cancer Urology · 1

PDF

Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress

2017 · A. A. Kirichek, B. Sh. Kamolov, et al. · Cancer Urology · 1

Cabozantinib in 2nd line of therapy after first-line sunitinib failure: a 4-year durable response in a patient with multifocal visceral renal cell carcinoma metastases (clinical observation)

2026 · Andrey A. Kirichek, E. A. Bratanova, et al. · Cancer Urology

PDF

Nephrotoxicity of combination drug therapy in metastatic renal cancer

2023 · K. S. Titov, E. V. Shutov, et al. · Cancer Urology

PDF

Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019)

2019 · A. A. Kirichek · Cancer Urology

PDF

Photorhabdus asymbiotica — новый представитель грамотрицательной микрофлоры в инфекции мочевых путей

2013 · Авдошин Владимир Павлович, Макаров Олег Викторович, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Works count: 18

Citation count: 67

H-index: 5

I10-index: 3